Katalog GES

Cancer Regression in Patients with Metastatic Melanoma after the Transfer of Autologous Antitumor Lymphocytes

Our recent clinical trials demonstrate that autologous cell transfer after lymphodepleting chemotherapy can cause the regression of large, vascularized tumors in patients with refractory metastatic melanoma. Eighteen of 35 patients treated with tumor-reactive lymphocyte cultures experienced an... Full description

1st Person: Rosenberg, Steven A.
Additional Persons: Dudley, Mark E.
Source: in Proceedings of the National Academy of Sciences of the United States of America Vol. 101 (2004), p. 14639-14645
More Articles
Type of Publication: Article
Language: English
Published: 2004
Online: Volltext
  Search for full text



Similar Items

Cannot find similar records

Library Services

Search Options

Quick links